WaferGen's Q3 Revenues Rise on SmartChip Sales | GenomeWeb

NEW YORK (GenomeWeb News) – WaferGen Biosystems today reported third-quarter revenues of $633,000, compared to $79,000 for the third quarter of 2009, as a result of its recently launched SmartChip system.

The Fremont, Calif.-based firm, which launched its SmartChip Real-Time PCR System in August, said that the majority of its revenues for the quarter came from the sales of systems, SmartChips, and gene-expression profiling services.

Get the full story

This story is free
for registered users

Registering provides access to this and other free content.

Register now.

Already have an account?
Login Now.

In Nucleic Acids Research this week: transcriptome patterns of Zika-infected cells, updated Comparative Toxicogenomics Database, and more.

BMJ study says that about half of former hematology-oncology regulators now work for industry.

Science should wish PhDs who leave academia well, a Nature editorial says.

New York-based doctors announce the birth of a baby boy whose parents underwent mitochondrial transfer therapy, New Scientist reports.